References
Hadam, M. R. Dopfer, R., Dammer, G., Derau, C., Niethammer, D. Expression of MHC-antigens in MHC-class-II-deficiency. In:Vossen, J., Griscelli, C. (eds.). Progress in immunodeficiency research and therapy, vol. II. Excerpta Medica, Amsterdam 1986, pp. 89–96.
Soe, G. B., Overturf, G. D. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev. Infect. Dis. 9 (1987) 719–736.
Ti, T. Y., Monteiro, E. H., Lam, S., Lee, H. S. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob. Agents Chemother. 28 (1985) 540–543.
Einhorn, M. S., Granoff, D. M. Failure of ceftriaxone therapy to eradicateSalmonella enteritidis from the gastrointestinal tract of neonates. Pediatr. Infect. Dis. J. 6 (1987) 1067–1068.
Ramirez, C. A., Bran, J. L., Mejia, C. R., Garcia, J. F. Open prospective study of the clinical efficacy of ciprofloxacin. Antimicrob. Agents Chemother. 28 (1985) 128–132.
Diridl, G., Pichler, H., Wolf, D. Treatment of chronic salmonella carriers with ciprofloxacin. Eur. J. Clin. Microbiol. 5 (1986) 260–261.
Hooper, D. C., Wolfson, J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 28 (1985) 716–721.
Alfaham, M., Holt, M. E., Goodchild, M. C. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin. Br. Med. J. 295 (1987) 699.
Kiess, W., Haas, R., Marget, W. Chloramphenicol-resistantSalmonella tennessee osteomyelitis. Infection 12 (1984) 359.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoppe, J.E., Dopfer, R., Huber, S. et al. Eradication of Salmonella dublin in an immunodeficient child by combined use of ceftriaxone and ciprofloxacin after failure of either agent alone. Infection 17, 399–400 (1989). https://doi.org/10.1007/BF01645558
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01645558